Pharmaceutical

Cure Genetics and Frametact seek gene cures for neurological ailments

Cure Genetics has entered a partnership and licensing deal with Frametact to develop gene therapy for familial neurological ailments.

Sep 15, 2023 - 20:00
Cure Genetics and Frametact seek gene cures for neurological ailments
Cure Genetics has entered a partnership and licensing deal with Frametact to develop gene therapy for familial neurological ailments.
Read the original article

Tags:

Previous Article

Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder

Next Article

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

As states ban gender-affirming care, Minnesota aims to be a refuge for trans youth

As states ban gender-affirming care, Minnesota aims to ...

Mar 28, 2023

STAT+: Pharmalittle: We’re reading about Sanders targeting pharma CEOs, insider trading, and more

STAT+: Pharmalittle: We’re reading about Sanders target...

Jan 20, 2024

Tislelizumab by BeiGene for Esophageal Squamous Cell Ca...

Dec 6, 2023